EXPORT CITATION

Chapter-61 Toxic Retinopathies

BOOK TITLE: Retina: Medical and Surgical Management

Author
1. Kumar Vinod
2. Kumar Pradeep
3. Tayade Akshay
4. Panwar Ajay
ISBN
9789352702947
DOI
10.5005/jp/books/18054_62
Edition
1/e
Publishing Year
2018
Pages
8
Author Affiliations
1. Mamata Medical College/Mamata General and Superspecialty Hospitals, Khammam, Andhra Pradesh, India, Sexual and Reproductive Healthcare, University, Hospitals Birmingham NHS Foundation Trust, Birmingham, England, UK, UK, Dr Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India, CCRYN; National Institute of Mental Health and Neuro Sciences (NIMHANS), Bengaluru, Karnataka, India, Dr Rajendra Prasad Center for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India, All India Institute of Medical Sciences, New Delhi, India, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India, St Stephens Hospital, New Delhi, India
2. University College of Medical Sciences (University of Delhi) and GTB Hospital, Delhi, India, State Institute of Mental Health, Pt BD Sharma University of Health Sciences Rohtak, Haryana, India, All India Institute of Medical Sciences, New Delhi, India, All India Institute of Medical Sciences, Patna, Bihar, India, All India Institute of Medical Sciences Patna, Bihar, India, Dr Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India
3. Dr Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India, All India Institute of Medical Sciences, New Delhi, India
4. Dr Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India, All India Institute of Medical Sciences, New Delhi, India
Chapter keywords
Toxic retinopathy, macular toxicity, antimalarial drug, phenothiazines, tamoxifen, canthaxanthin, talc

Abstract

The aim of this chapter is to focus on the toxic retinopathies. Macular toxicity has been reported with multiple medications and other exogenous substances. Some of these are antimalarial drugs, phenothiazines, tamoxifen, canthaxanthin, and talc. Chloroquine (Nivaquine, Avloclor) and hydroxychloroquine (Plaquenil) are used for treatment of malaria and rheumatological disorders (i.e. rheumatoid arthritis, lupus). Chloroquine-associated ocular side effects can be divided into three categories following as accommodation abnormality, corneal deposition, and pre- and true retinopathy. Thioridazine (Mellaril) and chlorpromazine (Largactil) are used in treating schizophrenia and related psychoses. Chlorpromazine is also used as a sedative. The usual dose of thioridazine is 150–600 mg/day, while chlorpromazine is 75–300 mg/day. Tamoxifen (Nolvadex, Emblon, Noltam, Tamofen) is an antiestrogen used to treat breast carcinoma. It has few systemic side effects at a traditional dose of 20–40 mg/day.

© 2019 Jaypee Brothers Medical Publishers (P) LTD.   |   All Rights Reserved